# US 2003/0224446 A1 · Method of predicting cytokine response to tissue injury

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0224446 A1
- Document ID: US20030224446A1
- Status: Published application
- Kind: A1
- Application number: 10/324,374
- Filed: 2002-12-19
- Published: 2003-12-04
- Earliest claimed: 2001-12-20
- Inventors: G. Jean Harry; Alessandra Bruccoleri; Donald Schmechel
- Web page: https://patentgrep.com/patent/US20030224446A1

## CPC

- G01N 33/92: involving lipids, e.g. cholesterol {, lipoproteins, or their receptors (steroid hormones G01N33/743)}
- G01N 33/6863: {Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors}
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

A method of predicting cytokine production in response to tissue injury by assaying for APOE

## Claims

### Claim 1

A method of providing the level of TNFβ produced by a human subject in response to tissue injury, including the steps of:
providing a sample of biological material from said subject;
assaying said sample for the presence of APOE;
on the basis of said assay, estimating the level of increase of TNFβ in said subject in response to tissue injury.

### Claim 2

A method of determining the increase of TNFβ levels produced by a human subject in response to a tissue injury, including the steps of:
providing a sample of biological material from said subject;
assaying said sample for the presence of APOE; and
estimating the level of increase of TNFβ in said subject by comparing said TNFP level of said subject to the TNFβ level of a second subject that has not suffered tissue injury.

### Claim 3

A method of predicting the level of TNFβ produced by a human subject following a tissue injury, including the steps of:
determining the age of the subject;
assaying a sample of biological material from said subject for the presence of APOE; and
estimating the level of TNFβ produced by the subject exposed to the tissue injury based on the age of the subject and the presence of APOE.
